Peng, L., Wang, R., Shang, J., Xiong, Y., & Fu, Z. (2017). Peroxiredoxin 2 is associated with colorectal cancer progression and poor survival of patients. Oncotarget.
Chicago-стиль цитированияPeng, LingLong, Rong Wang, JingKun Shang, YongFu Xiong, and ZhongXue Fu. "Peroxiredoxin 2 Is Associated With Colorectal Cancer Progression and Poor Survival of Patients." Oncotarget 2017.
MLA-цитированиеPeng, LingLong, et al. "Peroxiredoxin 2 Is Associated With Colorectal Cancer Progression and Poor Survival of Patients." Oncotarget 2017.
Предупреждение: эти цитированмия не могут быть всегда правильны на 100%.